PTGX

Protagonist Therapeutics (PTGX) Investor Questions

Protagonist Therapeutics (PTGX) investor questions: stock forecasts, price data, dividends, earnings dates, valuation and risk, with missing data clearly identified.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Protagonist Therapeutics
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
89
Annual revenue
$46.02M
Annual net income
$-130.15M
Annual free cash flow
$56.08M

Protagonist Therapeutics (PTGX) Investor Questions research

Protagonist Therapeutics trades under the ticker PTGX. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review PTGX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.

What is Protagonist Therapeutics (PTGX) stock?

Protagonist Therapeutics trades under ticker PTGX. Its recorded sector is Healthcare. Its industry is Biotechnology.

What does the PTGX stock forecast mean?

BTI's forecast summarizes available short-term and long-term research scores for PTGX. These scores are not price targets, analyst consensus or probabilities of a positive return. Compare the Forecast, Earnings and Valuation pages before interpreting the outlook.

Where can I find the PTGX stock price today?

Check the PTGX quote and chart in the research workspace, including currency, trading session and quote timestamp. The research-record update time on this page is not a live quote timestamp.

Does PTGX pay dividends?

Dividend yield is not supplied in this PTGX research record. Missing data does not establish that Protagonist Therapeutics does not pay dividends. Check the company's dividend announcements for declared amounts and dates.

When does PTGX report earnings?

The available earnings record lists 2026-08-18 for PTGX. This stored date may be historical; it is not confirmation of the next announcement. Check Protagonist Therapeutics's investor-relations calendar for the current schedule; estimated dates can change.

How can I assess PTGX's valuation and risk?

Compare Protagonist Therapeutics's financial results, cash flow, debt and valuation assumptions with its operating risks and competitors. The Financials, Valuation and Statistics pages provide the available figures. A BTI score is a research input, not a personalized recommendation.